443 related articles for article (PubMed ID: 21800234)
1. Clinical outcomes in patients with chronic kidney disease: a 5-year retrospective cohort study at a University Hospital in Japan.
Yamashita T; Yoshida T; Ogawa T; Tsuchiya K; Nitta K
Clin Exp Nephrol; 2011 Dec; 15(6):831-40. PubMed ID: 21800234
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of CKD patients receiving outpatient nephrology care in Italy.
De Nicola L; Chiodini P; Zoccali C; Borrelli S; Cianciaruso B; Di Iorio B; Santoro D; Giancaspro V; Abaterusso C; Gallo C; Conte G; Minutolo R;
Clin J Am Soc Nephrol; 2011 Oct; 6(10):2421-8. PubMed ID: 21817127
[TBL] [Abstract][Full Text] [Related]
3. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
Levin A; Djurdjev O; Beaulieu M; Er L
Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease.
Omae K; Ogawa T; Nitta K
Heart Vessels; 2010 May; 25(3):203-8. PubMed ID: 20512447
[TBL] [Abstract][Full Text] [Related]
5. Natural history of CKD stage 4 and 5 patients following referral to renal management clinic.
Zhang AH; Tam P; LeBlanc D; Zhong H; Chan CT; Bargman JM; Oreopoulos DG
Int Urol Nephrol; 2009 Dec; 41(4):977-82. PubMed ID: 19578968
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
Inaguma D; Imai E; Takeuchi A; Ohashi Y; Watanabe T; Nitta K; Akizawa T; Matsuo S; Makino H; Hishida A;
Clin Exp Nephrol; 2017 Jun; 21(3):446-456. PubMed ID: 27412450
[TBL] [Abstract][Full Text] [Related]
7. A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial.
Barrett BJ; Garg AX; Goeree R; Levin A; Molzahn A; Rigatto C; Singer J; Soltys G; Soroka S; Ayers D; Parfrey PS
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1241-7. PubMed ID: 21617090
[TBL] [Abstract][Full Text] [Related]
8. Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors.
Dattolo PC; Gallo P; Michelassi S; Paudice N; Cannavò R; Romoli E; Fani F; Tsalouchos A; Mehmetaj A; Ferro G; Sisca S; Pizzarelli F
J Nephrol; 2016 Dec; 29(6):809-815. PubMed ID: 27015900
[TBL] [Abstract][Full Text] [Related]
9. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort.
Obi Y; Kimura T; Nagasawa Y; Yamamoto R; Yasuda K; Sasaki K; Kitamura H; Imai E; Rakugi H; Isaka Y; Hayashi T
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1558-65. PubMed ID: 20558563
[TBL] [Abstract][Full Text] [Related]
10. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
[TBL] [Abstract][Full Text] [Related]
11. Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study.
Maruta Y; Hasegawa T; Yamakoshi E; Nishiwaki H; Koiwa F; Imai E; Hishida A
Clin Exp Nephrol; 2019 Feb; 23(2):215-222. PubMed ID: 30168046
[TBL] [Abstract][Full Text] [Related]
12. GFR decline and mortality risk among patients with chronic kidney disease.
Perkins RM; Bucaloiu ID; Kirchner HL; Ashouian N; Hartle JE; Yahya T
Clin J Am Soc Nephrol; 2011 Aug; 6(8):1879-86. PubMed ID: 21685022
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
Chen PM; Wada T; Chiang CK
Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
[TBL] [Abstract][Full Text] [Related]
14. Time-Varying Association of Individual BP Components with eGFR in Late-Stage CKD.
Sood MM; Akbari A; Manuel D; Ruzicka M; Hiremath S; Zimmerman D; McCormick B; Taljaard M
Clin J Am Soc Nephrol; 2017 Jun; 12(6):904-911. PubMed ID: 28356338
[TBL] [Abstract][Full Text] [Related]
15. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
[TBL] [Abstract][Full Text] [Related]
16. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent risk factors associated with the decline of estimated GFR in CKD patients.
Chang WX; Arai S; Tamura Y; Kumagai T; Ota T; Shibata S; Fujigaki Y; Shen ZY; Uchida S
Clin Exp Nephrol; 2016 Feb; 20(1):58-70. PubMed ID: 26100399
[TBL] [Abstract][Full Text] [Related]
18. Pulse pressure and progression of chronic kidney disease.
Arulkumaran N; Diwakar R; Tahir Z; Mohamed M; Kaski JC; Banerjee D
J Nephrol; 2010; 23(2):189-93. PubMed ID: 20119928
[TBL] [Abstract][Full Text] [Related]
19. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
20. Long-term fate of renal function after open surgery for juxtarenal and pararenal aortic aneurysm.
Sugimoto M; Takahashi N; Niimi K; Kodama A; Banno H; Komori K
J Vasc Surg; 2018 Apr; 67(4):1042-1050. PubMed ID: 28964618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
